TCTR20190805001Not yet recruiting未知
open-label randomised trial of tolvaptan plus low dose furosemide compared with high dose furosemide in patients with hospitalised heart failure
thai otsuka pharmaceutical0 sites70 target enrollmentStarted: August 5, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to 0 Years (—)
- Sex
- All
Inclusion Criteria
- •age> 18 years
- •hospitalised heart faillure by framingham criteria
Exclusion Criteria
- •-patient who receive more than two iv dose of furosemide 1 month or oral > 80 mg/day before randomisation
- •- allergy tolvaptan
- •- patient with serum sodium > 142 mol/L
- •- serum K <3.0 mol/l
- •- CKD > G3B (GFR< 30 by EPI)
- •- SBP < 90 mmHg
- •- sepsis or SOFA >= 2
Investigators
Similar Trials
Completed
Phase 3
Tolvaptan versus fluid restriction in acutely hospitalised patients with low blood sodium concentration.ACTRN12619001683123The University of Melbourne54
Recruiting
Not Applicable
A Randomized open label clinical trial for evaluation of efficacy and safety of Prazosin and Prazosin with scorpion anti- Venom combination in victims of venomous scorpion ( Mesobuthus Tamulus ) sting.CTRI/2010/091/000584il70
Completed
Not Applicable
Open randomized study for the evaluation of activities of AS/AQ (co-packaged and co-formulated) versus AL on asexual & sexual paraistes in childrePaediatricsMalariaPACTR201508001188143Swiss Pharma Nigeria Limited
Not yet recruiting
Not Applicable
Comparing standard treatment with topical anaesthetic cream in the treatment of postherpetic neuralgiaCTRI/2021/01/030847Dr R Sivayogana
Not yet recruiting
Not Applicable
Ayurvedic management of infected woundCTRI/2019/06/019867DR SAVITA LOKHANDE